메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
김지윤 (Korea University College of Medicine) 김경진 (고려대학교안암병원) 배재현 (고려대학교안암병원) 김주형 (Korea University College of Medicine) 김남훈 (고려대학교) 김희영 (Korea University College of Medicine) 김훈엽 (고려대학교) 백승국 (고려대학교) 김신곤 (고려대학교) 정광윤 (고려대학교) 김경진 (고려대학교)
저널정보
대한갑상선학회 International Journal of Thyroidology International Journal of Thyroidology 제14권 제2호
발행연도
2021.11
수록면
135 - 142 (8page)
DOI
10.11106/ijt.2021.14.2.135

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background and Objectives: The clinical implications of the BRAF V600E mutation in papillary thyroid microcarcinoma(PTMC), defined as ≤1.0 cm of tumor size, remain controversial. We investigated the associationbetween the BRAF V600E mutation and PTMC recurrence in a retrospective cohort of patients with thyroid cancer. Materials and Methods: This study included 2319 patients with PTMC (median age, 50 years [interquartile range(IQR), 41-57 years]) who underwent thyroid surgery from 2010 to 2019 at a single tertiary medical center. Themedian follow-up time was 75 months (IQR, 30-98 months). Tumor recurrence was confirmed by histological,cytological, radiographic, and biochemical criteria, combined with persistent and recurrent disease. Results: A totalof 60.2% (1395/2319) patients with PTMC had the BRAF V600E mutation. The tumor recurrence rate was 2.1%(19/924) in BRAF mutation-negative patients and 2.9% (41/1395) in BRAF mutation-positive patients, with ahazard ratio (HR) of 1.05 (95% confidence interval [CI], 0.61-1.84) after adjusting for clinicopathological riskfactors. Similar results were found in patients with high-risk PTMC (adjusted HR, 1.09; 95% CI, 0.56-2.11) whohad lymph node metastasis (LNM), extrathyroidal extension (ETE), or distant metastasis (DM) at diagnosis andin patients with low-risk PTMC (adjusted HR, 1.00; 95% CI, 0.35-2.83) who had no LNM, ETE, or DM. Conclusion:The finding that the BRAF V600E mutation was not associated with tumor recurrence in our cohort of Koreanpatients with PTMC, especially in patients with low-risk PTMC, suggests that its value in the prediction of diseaseprogression is limited.

목차

등록된 정보가 없습니다.

참고문헌 (30)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0